Description     Claims     Drawing  

US4376110A   [0061] 
US4486530A   [0061] 
USRE32011E   [0062] 
US4902614A   [0062] 
US4543439A   [0062] 
US4411993A   [0062] 
GB2272440A   [0066] 
US5569825A   [0066] 
US5545806A   [0066] 
WO8702671A   [0067] 
EP0184187A   [0067] 
EP0171496A   [0067] 
EP0173494A   [0067] 
WO8601533A   [0067] 
US4816567A   [0067] 
EP0125023A   [0067] 
US5225539A   [0067] 
WO9201047A   [0070]  [0071] 
WO9607754A   [0070] 
US5223409A   [0071] 
WO9218619A   [0071] 
WO9117271A   [0071] 
WO9220791A   [0071] 
WO9215679A   [0071] 
WO9301288A   [0071] 
WO9209690A   [0071] 
WO9002809A   [0071] 

J Mol Biol   [0031] 
Nucleic Acids Res   [0031] 
Nucleic Acids Res   [0031] 
Molecular Cloning   [0051] 
Current Protocols in Molecular Biology   [0051] 
Immuno Biology   [0057] 
Immuno Biology   [0057] 
Ann. N.Y. Acad. Sci.   [0060] 
Antibodies: A Laboratory Manual   [0061] 
Monoclonal Antibodies, Hybridomas: A New Dimension in Biological Analyses   [0062] 
Monoclonal Antibody Expression Libraries: A Rapid Alternative to Hybridomas   [0064] 
Biotechnology   [0064] 
Nature   [0066] 
PNAS   [0066] 
Bio/Technology   [0066] 
TIPS   [0066] 
Science   [0067] 
PNAS   [0067] 
J. Immunol.   [0067] 
PNAS   [0067] 
Canc. Res.   [0067] 
Nature   [0067] 
J. Natl. Cancer Inst.   [0067] 
Science   [0067] 
BioTechniques   [0067] 
Nature   [0067] 
Science   [0067] 
J. Immunol.   [0067] 
Ann NY Acad Sci   [0069] 
J. Mol. Biol.   [0070] 
EMBO J   [0070] 
Proc. Nat'l Acad. Sci. USA   [0070] 
Bio/Technology   [0071] 
Hum Antibod Hybridomas   [0071] 
Science   [0071] 
J Mol Biol   [0071] 
Nature   [0071] 
PNAS   [0071] 
Bio/Technology   [0071] 
Nuc Acid Res   [0071] 
PNAS   [0071] 
The Merck Manual   [0147] 
Goodman and Cilman's The pharmacological Basis of Therapeutics   [0147] 
CD4+ T-cell depletion in HIV infection: are we closer to understanding the cause?   [0249] 
HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells   [0249] 
HIV status, burden of comorbid disease and biomarkers of inflammation, altered coagulation, and monocyte activation   [0249] 
Regulatory dysfunction of the Interleukin-2 receptor during HIV-infection and the impact of triple combination therapy   [0249] 
Regulatory dysfunction of the interleukin-7 receptor in CD4 and CD8 lymphocytes from HIV-infected patients - effects of antiretroviral therapy   [0249] 
Human Immunodeficiency Virus - 1 envelope glycoproteins and anti-CD4 antibodies inhibit Interleukin-2 induced Jack/STAT signaling in human CD4 T lymphocytes   [0249] 
HIV infection perturbs IL-7 signaling at the step of STAT5 nuclear relocalization   [0249] 
IL-7 dependent STAT-5 activation and CD8+ T cell proliferation are impaired in HIV infection   [0249] 
Inverse association of repressor growth factor independent-1 with CD8 T cell interleukin (IL)-7 receptor [alpha] expression and limited signal transducers and activators of transcription signaling in response to IL-7 among [gamma]-chain cytokines in HIV patients   [0249] 
Interleukine-7 compartimentilizes its receptor signaling complex to initiate CD4 T lymphocyte response   [0249] 
Lipid rafts as a membrane-organizing principle   [0249] 
Membrane microdomains and cytoskeleton organisation shape and regulate the IL-7-receptor signalosome in human CD4 T-cells   [0249] 
HIV infection: pre-highly active antiretroviral therapy IL-7 plasma levels correlate with long term CD4 cell count increase after treatment   [0249] 
Identification and biochemical characterization of human plasma soluble IL-7R: lower concentrations in HIV-1 infected patients   [0249] 
Monitoring cellular immune markers in HIV infection: from activation to exhaustion   [0249] 
HIV-1 viremia prevents the establishment of interleukin-2 producing HIV-specific memory CD4+ T cells endowed with proliferative capacity   [0249] 
Disruption of the gamma c cytokine network in T cells during HIV infection   [0249] 
The role of interleukin-21 in HIV infection   [0249] 
HIV Controllers maintain a population of highly efficient TH1 effector in contrast to patients treated in the long term   [0249] 
Microbial translocation in HIV infection: causes, consequences and treatment opportunities   [0249]